Scientific publications using patient-derived iPSCs from the Stanford CVI Biobank

Resource Papers

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy. Liu L, Shenoy SP, Jahng JWS, Liu Y, Knowles JW, Zhuge Y, Wu JC. Stem Cell Res. 2021 05;53:102279.

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Jahng JWS, Black KE, Liu L, Bae HR, Perez M, Ashley EA, Sallam K, Wu JC. Stem Cell Res. 2021 05;53:102284.

Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome. Mondéjar-Parreño G, Jahng JWS, Belbachir N, Wu BC, Zhang X, Perez MV, Badhwar N, Wu JC. Stem Cell Res. 2021 07;54:102402.

Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Zhang H, Jahng JWS, Liu Y, Chase AJ, Perez MV, Wu JC. Stem Cell Res. 2021 08;55:102492.

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations. Cao X, Jahng JWS, Lee C, Zha Y, Wheeler MT, Sallam K, Wu JC. Stem Cell Res. 2021 08;55:102455.

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations. Zhao S, Shen MC, Lee C, Zha YJ, Guevara JV, Wheeler MT, Wu JC.

Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations. Belbachir N, Lai C, Rhee JW,  Zhuge Y, Perez MV, Sallam K, Wu JC. Stem Cell Res. 57 (2021) 102605

DCM Publications

HCM Publications

TOF Publications